ID

26343

Descripción

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: End of study Survival status

Palabras clave

  1. 10/10/17 10/10/17 -
  2. 16/10/17 16/10/17 -
  3. 23/10/17 23/10/17 -
  4. 11/1/18 11/1/18 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

16 de octubre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

End of study Survival status GSK study Chronic Coronary Heart Disease NCT00799903

End of study Survival status GSK study Chronic Coronary Heart Disease NCT00799903

Assessment date
Descripción

Assessment date

1. Most recent survival status assessment
Descripción

Most recent survival status assessment

Tipo de datos

date

Survival data
Descripción

Survival data

1. Subject status
Descripción

Subject status

Tipo de datos

integer

If subject known to be alive: Subject known to be alive on (date)
Descripción

Date Subject known to be alive

Tipo de datos

date

If subject known to be alive: Source of information
Descripción

Subject alive Source of information

Tipo de datos

text

If subject known to be alive: Other source of information, specify
Descripción

Subject alive Source of information specification

Tipo de datos

text

If subject died: date that site acquired death information
Descripción

date that site acquired death information

Tipo de datos

date

If subject died: Source of information
Descripción

death of subject Source of information

Tipo de datos

text

If subject died: Other source of information, specify
Descripción

Subject dead Source of information specification

Tipo de datos

text

Similar models

End of study Survival status GSK study Chronic Coronary Heart Disease NCT00799903

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Assessment date
Most recent survival status assessment
Item
1. Most recent survival status assessment
date
Item Group
Survival data
Item
1. Subject status
integer
Code List
1. Subject status
CL Item
Subject known to be alive (1)
CL Item
Subject died (2)
Date Subject known to be alive
Item
If subject known to be alive: Subject known to be alive on (date)
date
Item
If subject known to be alive: Source of information
text
Code List
If subject known to be alive: Source of information
CL Item
Health care provider other than investigative site staff (1)
CL Item
Family member (2)
CL Item
Publicly available information (3)
CL Item
Other (OT)
CL Item
Investigative site staff (4)
CL Item
Friend or neighbor (5)
Item
If subject known to be alive: Other source of information, specify
text
Code List
If subject known to be alive: Other source of information, specify
date that site acquired death information
Item
If subject died: date that site acquired death information
date
Item
If subject died: Source of information
text
Code List
If subject died: Source of information
CL Item
Health care provider other than investigative site staff (1)
CL Item
Family member (2)
CL Item
Publicly available information (3)
CL Item
Other (OT)
CL Item
Investigative site staff (4)
CL Item
Friend or neighbor (5)
Subject dead Source of information specification
Item
If subject died: Other source of information, specify
text

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial